PATENT CLAIM ANALYSIS

Application Number: 15754942
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["530", "332000"]

Abstract:
Provided are pharmaceutical formulations that include an amyloid polypeptide including at least one D-amino acid, and a pharmaceutically acceptable carrier. Also provided are kits that include the pharmaceutical formulations. Therapeutic methods that employ the pharmaceutical compositions are also provided, as are methods of forming racemic amyloid polypeptide aggregates involving the contacting of all-L amyloid polypeptide aggregates (e.g., oligomers) with amyloid polypeptides that include at least one D-amino acid. Methods for reducing solubility of an all-L amyloid polypeptide in a fluid, methods for characterizing an amyloid polypeptide of interest, and methods for removing an amyloid polypeptide from a bodily fluid, are also provided.

Claim (Index 1):
A pharmaceutical formulation, comprising:\n an amyloid polypeptide comprising at least one D-amino acid; and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 88.0
- Lexical Diversity: 2.03571
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14775272', '10301488', '12323944', '14265958', '10558656']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6938345835007588
- 35 USC 102 Novelty (BERT): 0.5127170751087768
- Combined Prediction Score: 0.6757228326615606
- Mean Citation Score: 290.1986320000001
- Max Citation Score: 294.07837
- Similarity Product: 194.32403628515723

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test